NCT04355234View on ClinicalTrials.gov

Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns

NACompletedINTERVENTIONAL

Enrollment

2,446

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions

Pregnancy

Interventions

DIAGNOSTIC_TEST

identify SARS-CoV-2 infection by serology

Blood samples at delivery to identify SARS-CoV-2 infection by serology

BIOLOGICAL

collection of biological samples

Creation of a specific collection of biological samples for new investigations thanks to the collection of several biological samples at the time of maternal SARS-CoV-2 infection, at delivery and in the postpartum period in the parturient and her newborn.

Trial Locations (1)

Unknown

Tsastaris Vassillis, Paris

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04355234 - Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns | Biotech Hunter | Biotech Hunter